Identification and subcellular localization of a new cystinosin isoform
Authors:
- Stefania PetriniSPStefania Petrini
- Alessia PalmaAPAlessia Palma
- Liliana MannucciLMLiliana Mannucci
- Martijn J. WilmerMWMartijn J. Wilmer
- Veronica De LucaVLVeronica De Luca
- Francesca Diomedi-CamasseiFDFrancesca Diomedi-Camassei
- Serena CoralliniSCSerena Corallini
- Francesco BellomoFBFrancesco Bellomo
- Lambert P. van Den HeuvelLHLambert P. van Den Heuvel
- Elena N. LevtchenkoELElena N. Levtchenko
- Francesco EmmaFEFrancesco Emma
- 1 May 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 294 (5) , F1101-F1108
Abstract
Nephropathic cystinosis is a lysosomal disorder caused by functional defects of cystinosin, which mediates cystine efflux into the cytosol. The protein sequence contains at least two signals that target the protein to the lysosomal compartment, one of which is located at the carboxy terminal tail (GYDQL). We have isolated from a human kidney cDNA library a cystinosin isoform, which is generated by an alternative splicing of exon 12 that removes the GYDQL motif. Based on its last three amino acids, we have termed this protein cystinosin-LKG. Contrary to the lysosomal cystinosin isoform, expression experiments performed by transient transfection of green fluorescent protein fusion plasmids in HK2 cells showed that cystinosin-LKG is expressed in the plasma membrane, in lysosomes, and in other cytosolic structures. This subcellular localization of the protein was confirmed by transmission electron microscopy. In addition, immunogold labeling was observed in the endoplasmic reticulum and in the Golgi apparatus. Expression of the protein in renal tubular structures was also directly demonstrated by immunostaining of normal human kidney sections. The plasma membrane localization of cystinosin-LKG was directly tested by [35S]cystine flux experiments in COS-1 cells. In the presence of a proton gradient, a marked enhancement of intracellular cystine transport was observed in cells overexpressing this isoform. These data indicate that the expression of the gene products encoded by the CTNS gene is not restricted to the lysosomal compartment. These finding may help elucidate the mechanisms of cell dysfunction in this disorder.Keywords
This publication has 29 references indexed in Scilit:
- Organelle identity and the signposts for membrane trafficNature, 2005
- Early oral cysteamine therapy for nephropathic cystinosisEuropean Journal of Pediatrics, 2003
- Structure, function and immunolocalization of a proton‐coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco‐2The Journal of Physiology, 2003
- Intralysosomal Cystine Accumulation in Mice Lacking Cystinosin, the Protein Defective in CystinosisMolecular and Cellular Biology, 2002
- Immunolocalization of Cystinosin, the Protein Defective in CystinosisJournal of the American Society of Nephrology, 2002
- CystinosisNew England Journal of Medicine, 2002
- Functional Characterization of Two Novel Mammalian Electrogenic Proton-dependent Amino Acid CotransportersJournal of Biological Chemistry, 2002
- The Targeting of Cystinosin to the Lysosomal Membrane Requires a Tyrosine-based Signal and a Novel Sorting MotifJournal of Biological Chemistry, 2001
- Identification of a renal cell line that constitutively expresses the kidney‐sp ecific high‐affinity H + /peptide cotransporterThe FASEB Journal, 1995
- Cysteamine Therapy for Children with Nephropathic CystinosisNew England Journal of Medicine, 1987